Scientific instrument company Bruker (NASDAQ: BRKR) will be announcing earnings results this Tuesday before market open. Here’s what to look for.
Bruker beat analysts’ revenue expectations last quarter, reporting revenues of $823.4 million, up 2.7% year on year. It was a very strong quarter for the company, with a beat of analysts’ EPS estimates and a solid beat of analysts’ organic revenue estimates.
Is Bruker a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Bruker’s revenue to grow 7.2% year on year, improving from its flat revenue in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Bruker has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Bruker’s peers in the research tools & consumables segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Avantor posted flat year-on-year revenue, beating analysts’ expectations by 4.9%, and Thermo Fisher reported revenues up 10.5%, topping estimates by 2.4%. Avantor traded up 11.6% following the results while Thermo Fisher was also up 7.9%.
Read our full analysis of Avantor’s results here and Thermo Fisher’s results here.
Investors in the research tools & consumables segment have had steady hands going into earnings, with share prices flat over the last month. Bruker is up 1.9% during the same time and is heading into earnings with an average analyst price target of $59.75 (compared to the current share price of $62.84).
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
